| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.3M | -46.1% |
| R&D Expense | $66.0M | +16.2% |
| SG&A Expense | $29.0M | -3.6% |
| Operating Income | -$91.5M | -26.3% |
| Income Tax | $0 | — |
| Net Income | -$89.3M | +20.0% |
| EPS (Basic) | -$0.36 | +62.5% |
| EPS (Diluted) | -$0.36 | +62.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $139.0M | -3.4% |
| Current Assets | $142.1M | -5.2% |
| Total Assets | $160.4M | -7.2% |
| Current Liabilities | $26.2M | -28.6% |
| Long-term Debt | $43.9M | +8.5% |
| Total Liabilities | $88.8M | -9.2% |
| Stockholders' Equity | $71.5M | -4.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.2M | -11.2% |
| Capital Expenditures | $374K | -90.3% |
| Investing Cash Flow | -$363K | +95.1% |
| Financing Cash Flow | $76.7M | -43.8% |
| Free Cash Flow | -$81.6M | -6.1% |